Cerebellum’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$60K Sell
478
-449
-48% -$55.6K 0.28% 280
2020
Q2
$81K Buy
+927
New +$96.4K 0.06% 360
2019
Q4
$560K Buy
3,790
+184
+5% +$24.7K 0.3% 94
2019
Q3
$434K Buy
3,606
+1,046
+41% +$135K 0.28% 211
2019
Q2
$346K Hold
2,560
0.28% 185
2019
Q1
$334K Buy
2,560
+546
+27% +$73.3K 0.29% 111
2018
Q4
$251K Buy
2,014
+623
+45% +$83.6K 0.17% 192
2018
Q3
$194K Sell
1,391
-320
-19% -$39.8K 0.31% 15
2018
Q2
$176K Sell
1,711
-192
-10% -$19.4K 0.29% 126
2018
Q1
$185K Buy
1,903
+976
+105% +$94.7K 0.24% 196
2017
Q4
$81K Buy
+927
New +$74.5K 0.06% 360

Other funds holding HCA

Cerebellum's HCA Position: Q3 2020 in Review

Cerebellum reduced its HCA Healthcare (HCA) stake by 48% in Q3 2020, selling an estimated $55.6K and leaving 478 shares worth $60K. The position accounts for 0.28% of the portfolio, ranked #280.

Cerebellum first reported a position in HCA in Q4 2017 and has held it in 11 quarters since. The position peaked at $560K in Q4 2019. 718 funds tracked by Wall St. Rank hold HCA as of Q3 2020.

  • Cerebellum held 478 shares of HCA Healthcare worth $60K as of Q3 2020.
  • Cerebellum sold 449 HCA Healthcare shares in Q3 2020, an estimated $55.6K.
  • HCA Healthcare made up 0.28% of Cerebellum's portfolio in Q3 2020, its #280 holding.
  • Cerebellum first reported a position in HCA Healthcare in Q4 2017 and has held it in 11 quarters since.
  • Cerebellum's HCA Healthcare position peaked at $560K in Q4 2019.
  • 718 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.